Glycosidase inhibitors
US10556902B2 · kind B2 · utility
12Cited by
10References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2017 |
| Grant date | Feb 11, 2020 |
| Priority date | — |
| Expiry date | Feb 24, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.